US Patent 11059801 Methods to induce targeted protein degradation through bifunctional molecules
Patent 11059801 was granted and assigned to Dana-Farber Cancer Institute on July, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+488 characters)
Article
Patent abstract
The present application provides bifunctional compounds which act as protein degradation inducing moieties. The present application also relates to methods for the targeted degradation of endogenous proteins through the use of the bifunctional compounds that link a cereblon-binding moiety to a ligand that is capable of binding to the targeted protein which can be utilized in the treatment of cancer. The present application also provides compounds of Formula X0 and X0′:
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Dennis Buckley0
Georg Winter0
James Bradner0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Sep, 2022
Golden AI
Infobox
Golden AI
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 12 Feb, 2022
Golden AI
Edits made to:
Infobox (+11 properties)
US Patent 11059801 Methods to induce targeted protein degradation through bifunctional molecules
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11059801
Date of patent
July 13, 2021
Patent application number
16838656
Date Filed
April 2, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 11059801 Methods to induce targeted protein degradation through bifunctional molecules
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
